CLINICAL_TRIALS
trial_result
· 2023-03-09
Clinical Trial Update: Extended Pelvic Lymph Node Dissection vs. no Pelvic Lymph Node Dissection at Radical Prostatectomy for intermediate-and High-risk Prostate Cancer [Phase 3]
Summary
A Phase 3 trial comparing extended pelvic lymph node dissection versus no pelvic lymph node dissection during radical prostatectomy in intermediate- and high-ri…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Swiss Cancer Institute | Conditions: Prostate Cancer | Phase 3 | Status: TERMINATED